Novo Nordisk A S NVO Income Statement (2012-2017)

NYSE NVO
$39.15 +0.86 (+2.25%)
At close: Oct 29, 2026 · 4:00 PM EDT
Reported Financials

Novo Nordisk A S Quarterly Income Statement

Periods 24 quarters
Latest Dec 2017

Novo Nordisk A S reported revenue of $4.42B and net income of $1.31B for the quarter ended Dec 2017, up 3.0% year over year. This income statement covers 24 quarters of results from Mar 2012 through Dec 2017, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017
Revenue & cost
Revenue
3,537.00M3,749.00M3,643.00M3,950.00M3,734.00M3,975.00M3,957.00M88,806.00M3,808.00M4,004.00M3,991.00M107,927.00M4,017.00M4,165.00M4,130.00M4,290.00M4,073.00M4,230.00M4,198.00M4,418.00M
Cost of RevenueCost of Rev
639.00M632.00M626.00M620.00M637.00M674.00M608.00M85,337.00M586.00M570.00M573.00M104,365.00M625.00M614.00M598.00M715.00M608.00M651.00M672.00M740.00M
Gross Profit
2,898.00M3,117.00M3,017.00M3,330.00M3,097.00M3,301.00M3,349.00M3,469.00M3,222.00M3,434.00M3,418.00M3,562.00M3,392.00M3,551.00M3,532.00M3,575.00M3,465.00M3,579.00M3,526.00M3,678.00M
Operating items
Research & DevelopmentR&D
470.00M476.00M497.00M646.00M581.00M566.00M651.00M652.00M491.00M448.00M491.00M593.00M488.00M505.00M519.00M651.00M471.00M504.00M523.00M625.00M
Other Operating ExpensesOther Opex
31.00M31.00M27.00M32.00M39.00M38.00M30.00M30.00M420.00M52.00M34.00M12.00M42.00M24.00M30.00M13.00M40.00M28.00M65.00M25.00M
Operating ExpensesOpex
470.00M476.00M497.00M646.00M581.00M566.00M651.00M652.00M491.00M448.00M491.00M593.00M488.00M505.00M519.00M651.00M471.00M504.00M523.00M625.00M
Operating IncomeOp. Inc
1,339.00M1,505.00M1,420.00M1,343.00M1,474.00M1,606.00M1,522.00M1,538.00M2,094.00M1,843.00M1,784.00M1,629.00M1,817.00M1,895.00M1,863.00M1,618.00M1,931.00M1,978.00M1,904.00M1,604.00M
Non-operating items
Non Operating Interest Expenses
19.00M47.00M20.00M31.00M58.00M26.00M79.00M-63.00M251.00M252.00M276.00M121.00M55.00M17.00M36.00M106.00M172.00M3.00M-49.00M
Interest & Investment IncomeInt & Inv Inc
55.00M65.00M73.00M110.00M108.00M72.00M58.00M-208.00M43.00M-34.00M1.00M3.00M3.00M15.00M-1.00M-3.00M37.00M62.00M61.00M29.00M
Non Operating IncomeNon Op. Inc.
-208.00M-286.00M-275.00M-118.00M-52.00M15.00M-18.00M-39.00M-69.00M-110.00M58.00M78.00M
Net income details
EBIT
1,339.00M1,505.00M1,420.00M1,343.00M1,474.00M1,606.00M1,522.00M1,538.00M2,094.00M1,843.00M1,784.00M1,629.00M1,817.00M1,895.00M1,863.00M1,618.00M1,931.00M1,978.00M1,904.00M1,604.00M
EBT
1,375.00M1,523.00M1,473.00M1,422.00M339.00M366.00M348.00M303.00M1,886.00M1,557.00M1,509.00M1,511.00M1,765.00M1,910.00M1,845.00M1,579.00M1,862.00M1,868.00M1,962.00M1,682.00M
Tax ProvisionsTaxes
1,524.00M1,652.00M1,501.00M7,615.00M394.00M326.00M260.00M301.00M369.00M399.00M375.00M323.00M408.00M398.00M424.00M368.00M
Income After Tax
1,375.00M1,523.00M1,473.00M1,422.00M-1,185.00M-1,286.00M-1,153.00M-7,312.00M1,492.00M1,231.00M1,249.00M1,210.00M1,396.00M1,511.00M1,470.00M1,256.00M1,454.00M1,470.00M1,538.00M1,314.00M
Income from Continuing OperationsIncome (Continuing)
1,375.00M1,523.00M1,473.00M1,422.00M-1,185.00M-1,286.00M-1,153.00M-7,312.00M1,492.00M1,231.00M1,249.00M1,210.00M1,396.00M1,511.00M1,470.00M1,256.00M1,454.00M1,470.00M1,538.00M1,314.00M
Consolidated Net IncomeConsol Net Inc.
1,059.00M1,181.00M1,139.00M1,105.00M1,185.00M1,286.00M1,153.00M1,090.00M1,492.00M1,231.00M1,249.00M1,210.00M1,396.00M1,511.00M1,470.00M1,256.00M1,454.00M1,470.00M1,538.00M1,314.00M
Income towards Parent CompanyParent Net Inc
1,059.00M1,181.00M1,139.00M1,105.00M1,185.00M1,286.00M1,153.00M1,090.00M1,492.00M1,231.00M1,249.00M1,210.00M1,396.00M1,511.00M1,470.00M1,256.00M1,454.00M1,470.00M1,538.00M1,314.00M
Net Income towards Common StockholdersNet Income
1,059.00M1,181.00M1,139.00M1,105.00M1,185.00M1,286.00M1,153.00M1,090.00M1,492.00M1,231.00M1,249.00M1,210.00M1,396.00M1,511.00M1,470.00M1,256.00M1,454.00M1,470.00M1,538.00M1,314.00M
Additional items
EBITDA
1,461.00M1,624.00M1,534.00M4,142.00M1,595.00M1,728.00M1,734.00M4,973.00M2,194.00M1,939.00M1,878.00M1,779.00M1,909.00M2,004.00M1,973.00M1,781.00M2,032.00M2,105.00M2,016.00M1,746.00M
Interest ExpensesInt Expense
19.00M47.00M20.00M31.00M58.00M26.00M79.00M-63.00M251.00M252.00M276.00M121.00M55.00M17.00M36.00M106.00M172.00M3.00M-49.00M
Tax Rate
449.56%451.37%431.32%2,513.20%20.89%20.94%17.23%19.92%20.91%20.89%20.33%20.46%21.91%21.31%21.61%21.88%

Novo Nordisk A S Income Statement API

Pull Novo Nordisk A S's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NVO&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY